|
|
 |
|
Viewing report
|
|
|
|
Stem Cells Market And Drug Discovery Applications, 2009-2015
Axis Research Mind, July 2010, Pages: 410
The ‘Stem Cells Market and Drug Discovery applications, 2009-2015’ reviews latest Stem Cells market trends with a perceptive to disclose the near-future growth prospects. An in-depth analysis across the geographic regions provides strategic business intelligence for life science and as well as healthcare sector investments. The study offers profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.
The report primarily focuses on:
- Latest Market Trends
- Region-wise Demand Factor
- Key Growth Areas
- Market Sizes
- Key Competitors Edge
- Investment Strategies
The report delivers a microscopic study of major stem cells product segments and applications of drug discovery in stem cells market, worldwide. The stem cells product segments include adult stem cells, cord blood stem cells, embryonic stem cells and others. The major stem cells drug discovery applications discussed in the report are:
- Cell Therapy and Regenerative Medicine
- High-Content Screening Assays and Toxicology
- Replacement of Damaged Cells
The report centers on major current market trends, estimates and forecasts for the period 2009-2015. More than 500 leading market players are identified and 37 key companies that project improved market activities in the coming years are profiled. The report consists of 253 data charts describing market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.
The region-wise distribution of the market consists of North America (USA, Canada and Mexico); Europe (Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom and Rest of Europe); Asia-Pacific (Australia, China, India, Japan, South Korea and Rest of Asia-Pacific); Latin America (Argentina and Brazil) and Rest of the World (Columbia, Middle East, South Africa and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan and China along with the other emerging countries are estimated individually for the upcoming years. Anticipating a protracted economic recovery towards to 2011 and based on the CAGR estimates and growth potential, we have forecasted the market size figures for the next five years.
Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the stem cells industry.
GLOBAL MARKET WATCH:
Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015. In terms of drug discovery applications using stem cells, North America and Europe account for more than 60% of the market value. However, the largest growth rate during 2009-2015 is expected from Asia-Pacific, a CAGR of 26.5%. China, India, Greece, Spain, Sweden, Germany and the US are at the forefront in driving the sector growth with an annual growth rate of more than 27% during the period. Brazil and Argentina are the Latin American majors in drug discovery applications using stem cells. Stem cells use in replacing damaged cells is expected to witness highest investments in the upcoming years as the CAGR forecasts for the sector is high. Estimates for cell therapy and regenerative medicine market indicate a CAGR of nearly 24% CAGR during 2009-2015.
The stem cell market is expected to witness a substantial growth in the upcoming years, with a CAGR of 24.2%, globally. Although North America will likely post highest market value by 2015, Asian economies are expected to maintain large CAGR of 27 percent during 2010-2015. The higher growth rate indicates improved industry investments in the Asia-Pacific region in comparison with North America and Europe, going ahead.
Improving health consciousness in Europe will likely maintain the stem cell market of the European Union competent with Asia-Pacific/North America. India possesses the potential to occupy the leading position in stem cell market growth with a CAGR exceeding 28 percent through 2015. Spain, Sweden and Germany are anticipated to top among the European countries with an annual compounded growth rate of more than 27 percent respectively through 2010-2015. Latin American countries will not likely experience a massive growth rate in comparison with North American/Asian economies. Overall, emerging economies could tag higher growth rate stem cells market in the next few years.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Stem Cells Market And Applications, 2009-2015
Stem Cells Market And Technologies, 2009-2015
Human Embryonic Stem Cells (hESC) - A Global Market Overview
Biobanking: Applications - A Global Market Watch, 2009-2015
Biorepositories: Applications & Ownership - A Global Market Watch, 2009-2015
Biorepositories: Applications & End-Users - A Global Market Watch, 2009-2015
Biobanking: End-Users - A Global Market Watch, 2009-2015
Biorepositories: Applications & Technologies - A Global Market Watch, 2009-2015
Biobanking: Technologies - A Global Market Watch, 2009-2015
Biobanking: Ownership - A Global Market Watch, 2009-2015
|
|
|
|
